Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar;24(3):536-543.
doi: 10.1002/ejp.1503. Epub 2019 Nov 25.

Analgesic efficacy of 10% lidocaine spray during nasoenteral catheterization: Randomized triple-blind trial

Affiliations
Randomized Controlled Trial

Analgesic efficacy of 10% lidocaine spray during nasoenteral catheterization: Randomized triple-blind trial

Amanda Santos de Oliveira et al. Eur J Pain. 2020 Mar.

Abstract

Background: Pain is a common experience during nasoenteral catheterization. Although the procedure causes discomfort and distress to patients, procedural pain remains neglected and undertreated.

Objective: To evaluate the analgesic efficacy of the use of 10% lidocaine spray during nasoenteral catheterization.

Method: A randomized, triple-blind trial of 50 patients was performed. The patients were randomly assigned to two groups: an intervention group (IG), in which 10% lidocaine spray combined with 2% lidocaine gel was used, and a control group (CG), in which a saline solution spray combined with 2% lidocaine gel was used. Pain and discomfort were assessed during and after nasoenteral catheterization using numerical rating scale (NRS) and the visual analogue scale (VAS), respectively.

Results: Intervention group participants reported lower pain scores during (0.20 ± 0.71 vs. 5.00 ± 2.84, p < .001; |d| = -0.677) and after (0.00 ± 0.00 vs. 2.80 ± 2.83, p < .001; |d| = -0.718) nasoenteral catheterization compared to the CG.

Conclusion: Spraying 10% lidocaine spray before nasoenteral catheterization was most effective for relieving discomfort and pain, with lower pain and discomfort recorded in NRS and VAS. Topical administration of 10% lidocaine spray is therefore a suggested measure for procedural pain relief related to nasoenteral catheterization.

Significance: The use of 10% lidocaine spray was more effective in relieving procedural pain and discomfort during nasoenteral catheterization. Patients who received 10% lidocaine spray registered lower discomfort and pain scores than those from 2% lidocaine gel group; there were less complications among patients in the IG.

PubMed Disclaimer

References

REFERENCES

    1. Cliff, N. (2014). Ordinal methods for behavioral data analysis. USA: Psychology Press.
    1. Cullen, L., Taylor, D., Taylor, S., & Chu, K. (2004). Nebulized lidocaine decreases the discomfort of nasogastric tube insertion: A randomized, double-blind trial. Annals of Emergency Medicine, 44, 131-137. https://doi.org/10.1016/j.annemergmed.2004.03.033
    1. Czarnecki, M. L., Turner, H. N., Collins, P. M., Doellman, D., Wrona, S., & Reynolds, J. (2011). Procedural pain management: A position statement with clinical practice recommendations. Pain Management Nursing, 12, 95-111. https://doi.org/10.1016/j.pmn.2011.02.003
    1. Fisher, R. A. (1922). On the interpretation of from contingency tables, and the calculation of p. Journal of the Royal Statistical Society, 85, 87-94.
    1. Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008). GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336, 924-926. https://doi.org/10.1136/bmj.39489.470347.AD

Publication types

LinkOut - more resources